Business · 19/05/2003Updated: 10/17/2026 · 1 min read
FDA Releases Draft Guidances for Medical Imaging Drug and Biological Products
Summary
The Food and Drug Administration (FDA) has made available three draft guidances to help medical imaging product developers prepare and submit regulatory applications, including INDs and NDAs, for their imaging agents
Original source language: Federal Register — Food and Drug AdministrationOpen original release →